FDA issued a Warning Letter to Celltrion Inc. on 1/26/2018 for a previous inspection.
483 Celltrion Jul 2018

483 Celltrion Jul 2018

Jacek Cieslak FDA, Richard Ledwidge FDA, Ashar Parikh FDA$119.00 - Available Now

FDA investigators audited the Celltrion - Incheon City, Korea (the Republic of) facility and issued inspectional observations (via FDA 483) on 17 Jul 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 17 Jul 2018
  • Location: Incheon City, Korea (the Republic of)
  • FEI: 3005241015
Add To Cart